# HF2 Therapy in the Treatment of Active Ulcerative Colitis

> **NCT03720002** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sheba Medical Center** · enrollment: 52 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DIETARY_SUPPLEMENT:** HF2

## Key facts

- **NCT ID:** NCT03720002
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-29
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-02-01
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2023-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03720002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03720002, "HF2 Therapy in the Treatment of Active Ulcerative Colitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03720002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*